Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan.
Suda G, Furusyo N, Toyoda H, Kawakami Y, Ikeda H, Suzuki M, Arataki K, Mori N, Tsuji K, Katamura Y, Takaguchi K, Ishikawa T, Tsuji K, Shimada N, Hiraoka A, Yamsaki S, Nakai M, Sho T, Morikawa K, Ogawa K, Kudo M, Nagasaka A, Furuya K, Yamamoto Y, Kato K, Ueno Y, Iio E, Tanaka Y, Kurosaki M, Kumada T, Chayama K, Sakamoto N. Suda G, et al. Among authors: suzuki m. J Gastroenterol. 2018 Jan;53(1):119-128. doi: 10.1007/s00535-017-1353-y. Epub 2017 May 30. J Gastroenterol. 2018. PMID: 28560477
Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b.
Matsumoto N, Ikeda H, Shigefuku R, Hattori N, Watanabe T, Matsunaga K, Hiraishi T, Tamura T, Noguchi Y, Fukuda Y, Ishii T, Okuse C, Sato A, Suzuki M, Itoh F. Matsumoto N, et al. Among authors: suzuki m. PLoS One. 2016 Mar 18;11(3):e0151238. doi: 10.1371/journal.pone.0151238. eCollection 2016. PLoS One. 2016. PMID: 26990758 Free PMC article.
Impact of resistance-associated variant dominancy on treatment in patients with HCV genotype 1b receiving daclatasvir/asunaprevir.
Ikeda H, Watanabe T, Okuse C, Matsumoto N, Ishii T, Yamada N, Shigefuku R, Hattori N, Matsunaga K, Nakano H, Hiraishi T, Kobayashi M, Yasuda K, Yamamoto H, Yasuda H, Kurosaki M, Izumi N, Yotsuyanagi H, Suzuki M, Itoh F. Ikeda H, et al. Among authors: suzuki m. J Med Virol. 2017 Jan;89(1):99-105. doi: 10.1002/jmv.24608. Epub 2016 Jul 6. J Med Virol. 2017. PMID: 27329864
Acute hepatitis B of genotype H resulting in persistent infection.
Yamada N, Shigefuku R, Sugiyama R, Kobayashi M, Ikeda H, Takahashi H, Okuse C, Suzuki M, Itoh F, Yotsuyanagi H, Yasuda K, Moriya K, Koike K, Wakita T, Kato T. Yamada N, et al. Among authors: suzuki m. World J Gastroenterol. 2014 Mar 21;20(11):3044-9. doi: 10.3748/wjg.v20.i11.3044. World J Gastroenterol. 2014. PMID: 24659896 Free PMC article.
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?
Ikeda H, Okuse C, Watanabe T, Matsumoto N, Matsunaga K, Shigefuku R, Hattori N, Hiraishi T, Fukuda Y, Noguchi Y, Ishii T, Shima J, Nakahara K, Yamamoto H, Yasuda H, Yotsuyanagi H, Koike K, Itoh F, Suzuki M. Ikeda H, et al. Among authors: suzuki m. Turk J Gastroenterol. 2016 Mar;27(2):165-72. doi: 10.5152/tjg.2016.150300. Turk J Gastroenterol. 2016. PMID: 27015621 Free article.
Daclatasvir and asunaprevir improves health-related quality of life in Japanese patients infected with hepatitis C virus.
Ikeda H, Watanabe T, Matsumoto N, Hiraishi T, Nakano H, Noguchi Y, Hattori N, Shigefuku R, Yamashita M, Nakahara K, Matsunaga K, Okuse C, Yotsuyanagi H, Tanaka A, Suzuki M, Itoh F. Ikeda H, et al. Among authors: suzuki m. JGH Open. 2018 May 14;2(3):87-92. doi: 10.1002/jgh3.12052. eCollection 2018 Jun. JGH Open. 2018. PMID: 30483569 Free PMC article.
Molecular epidemiology of hepatitis A virus in metropolitan areas in Japan.
Takahashi H, Yotsuyanagi H, Yasuda K, Koibuchi T, Suzuki M, Kato T, Nakamura T, Iwamoto A, Nishioka K, Iino S, Koike K, Itoh F. Takahashi H, et al. Among authors: suzuki m. J Gastroenterol. 2006 Oct;41(10):981-6. doi: 10.1007/s00535-006-1888-9. Epub 2006 Nov 9. J Gastroenterol. 2006. PMID: 17096067
Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?
Shigefuku R, Takahashi H, Kobayashi M, Ikeda H, Matsunaga K, Okuse C, Matsumoto N, Maeyama S, Sase S, Suzuki M, Itoh F. Shigefuku R, et al. Among authors: suzuki m. J Gastroenterol. 2012 Nov;47(11):1238-47. doi: 10.1007/s00535-012-0581-4. Epub 2012 May 11. J Gastroenterol. 2012. PMID: 22576023 Clinical Trial.
Risk factors for liver-related mortality of patients with hepatitis C virus after sustained virologic response to direct-acting antiviral agents.
Hattori N, Ikeda H, Watanabe T, Satta Y, Ehira T, Suzuki T, Kiyokawa H, Nakahara K, Takahashi H, Matsunaga K, Matsumoto N, Yasuda H, Suzuki M, Itoh F, Tateishi K. Hattori N, et al. Among authors: suzuki m, suzuki t. JGH Open. 2022 Aug 26;6(10):685-691. doi: 10.1002/jgh3.12805. eCollection 2022 Oct. JGH Open. 2022. PMID: 36262540 Free PMC article.
15,416 results
You have reached the last available page of results. Please see the User Guide for more information.